BioCentury
ARTICLE | Company News

Jazz Pharmaceuticals sales and marketing update

February 24, 2014 8:00 AM UTC

Jazz launched Versacloz clozapine in the U.S. to treat severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective di...